Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01725451 · ClinicalTrials.gov registry record · Phase 1
A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy Participants
A Phase 1 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT01725451 is a Phase 1 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 30 participants.
The verdict
NCT01725451, a Phase 1 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study will evaluate the effect of deodorant and antiperspirant use and the presence of underarm hair on the absorption of testosterone. Each participant in this study will receive 6 single doses of 30 milligrams (mg) testosterone applied as a solution to each underarm. There is a minimum one day washout period between each dose. This study will last approximately 24 days not including screening. Screening is required within 30 days prior to the start of the study.
Interventions
- DRUG Testosterone
- OTHER Deodorant Spray
- OTHER Deodorant and Antiperspirant Combination Spray
- OTHER Deodorant and Antiperspirant Combination Stick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-11 |
| Est. Completion | 2013-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01725451
The ClinicalTrials.gov registry entry for NCT01725451 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Testosterone is the first listed.
NCT01725451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01725451 about?
NCT01725451 is a clinical study titled "A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy Participants". This study will evaluate the effect of deodorant and antiperspirant use and the presence of underarm hair on the absorption of testosterone. Each participant in this study will receive 6 single doses of 30 milligrams (mg) testosterone applied as a solution to each underarm. There is a minimum one da...
What is the current status of trial NCT01725451?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2012-11. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01725451?
The interventions under investigation include: Testosterone (DRUG), Deodorant Spray (OTHER), Deodorant and Antiperspirant Combination Spray (OTHER), Deodorant and Antiperspirant Combination Stick (OTHER).
Who is sponsoring clinical trial NCT01725451?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.